Fulgent Genetics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Fulgent Genetics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2016 to Q2 2024.
  • Fulgent Genetics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $11.6M, a 12.7% increase year-over-year.
  • Fulgent Genetics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $45.5M, a 14.9% increase year-over-year.
  • Fulgent Genetics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $42.9M, a 31.5% increase from 2022.
  • Fulgent Genetics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $32.6M, a 106% increase from 2021.
  • Fulgent Genetics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $15.9M, a 94.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $45.5M $11.6M +$1.31M +12.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $44.2M $11.5M +$1.25M +12.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $42.9M $11.4M +$1.41M +14.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $41.5M $10.9M +$1.93M +21.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $39.6M $10.3M +$2.29M +28.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $37.3M $10.3M +$4.65M +82.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $32.6M $10M +$5M +99.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $27.6M $8.97M +$4.6M +105% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $23M $8.03M +$4.5M +128% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $18.5M $5.62M +$2.65M +89.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $15.9M $5.02M +$2.02M +67.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $13.9M $4.37M +$1.22M +38.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $12.6M $3.53M +$2.45M +226% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $10.2M $2.96M +$2.04M +221% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $8.16M $3M +$2.07M +220% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $6.09M $3.15M +$2.2M +231% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $3.89M $1.08M +$343K +46.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $3.55M $924K +$341K +58.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $3.21M $938K +$340K +56.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $2.87M $951K +$363K +61.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $2.51M $737K +$164K +28.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $2.34M $583K +$38K +6.97% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $2.3M $598K +$17K +2.93% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 $2.29M $588K +$39K +7.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $2.25M $573K +$149K +35.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $2.1M $545K -$20K -3.54% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $2.12M $581K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 $549K -$1.94M -78% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $424K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 $565K -$1.06M -65.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q3 2016 $2.49M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q1 2016 $1.63M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.